SHA:600535 Market Cap

SHA:600535 has a market cap or net worth of 21.56 billion as of May 19, 2026. Its market cap has decreased by -5.50% in one year.

Market Cap

21.56B

Enterprise Value

18.49B

Revenue

8.35B

Ranking

n/a

PE Ratio

18.57

Stock Price

14.17

Market Cap Chart

Since November 3, 2004, SHA:600535's market cap has increased from 3.65B to 21.56B, an increase of 490.95%. That is a compound annual growth rate of 8.59%.

Market Cap History

Date	Market Cap	% Change
May 18, 2026	21.47B	-4.64%
Dec 31, 2025	22.51B	4.22%
Dec 31, 2024	21.60B	-15.04%
Dec 29, 2023	25.43B	59.04%
Dec 30, 2022	15.99B	-32.76%
Dec 31, 2021	23.78B	6.62%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Dizal (Jiangsu) Pharmaceutical	23.70B
Walvax Biotechnology	22.69B
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	22.54B
Kangmei Pharmaceutical	21.99B
Hybio Pharmaceutical	21.47B
Jilin Aodong Pharmaceutical Group	20.94B
Jiangsu Nhwa Pharmaceutical Co., LTD	20.89B
Betta Pharmaceuticals	20.49B

Market Cap Rankings